U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. S5(R3) Detection of Toxicity to Reproduction
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

S5(R3) Detection of Toxicity to Reproduction November 2017

Draft

Not for implementation. Contains non-binding recommendations.

Docket Number:
FDA-2017-D-5138
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

This guideline applies to pharmaceuticals, including biotechnology-derived pharmaceuticals, vaccines (and their novel constitutive ingredients) for infectious diseases, and novel excipients that are part of the final pharmaceutical product. It does not apply to cellular therapies, gene therapies and tissue-engineered products.


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2017-D-5138.

Back to Top